|
|||||
|
|
Ginsenoside Rg5 inhibits cancer cell migration by inhibiting the nuclear factor-κB and erythropoietin-producing hepatocellular receptor A2 signaling pathways |
|
| Authors: | Leixin Song Fan Yang Zhengtao Wang Li Yang Yue Zhou |
| Affiliation: | 1.The MOE Key Laboratory for Standardization of Chinese Medicines and The SATCM Key Laboratory for New Resources and Quality Evaluation of Chinese Medicines, Institute of Chinese Materia Medica, Shanghai University of Traditional Chinese Medicine, Shanghai 201203, P.R. China;2.Shanghai R&D Centre for Standardization of Chinese Medicines, Shanghai 201203, P.R. China;3.Department of Cancer Cell Biology, Faculty of Pharmaceutical Sciences, University of Toyama, Toyama 9300194, Japan |
| Abstract: | |
| Keywords: | ginsenoside Rg5, nuclear factor-κ B, transforming growth factor β -activated kinase 1, erythropoietin-producing hepatocellular receptor A2, cancer migration |